Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

Epigenetic and genetic alterations of p33ING1b in ovarian cancer.

Shen DH, Chan KY, Khoo US, Ngan HY, Xue WC, Chiu PM, Ip P, Cheung AN.

Carcinogenesis. 2005 Apr;26(4):855-63. Epub 2005 Jan 27.

2.

Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.

Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC Jr.

Cancer. 2008 Apr 1;112(7):1489-502. doi: 10.1002/cncr.23323.

3.

P73 gene expression in ovarian cancer tissues and cell lines.

Chen CL, Ip SM, Cheng D, Wong LC, Ngan HY.

Clin Cancer Res. 2000 Oct;6(10):3910-5.

4.

Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.

Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I.

Cancer Res. 2007 Aug 1;67(15):7095-105.

5.

Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer.

Yanaihara N, Nishioka M, Kohno T, Otsuka A, Okamoto A, Ochiai K, Tanaka T, Yokota J.

Int J Cancer. 2004 Oct 20;112(1):150-4.

6.

Epigenetic modification is involved in aberrant expression of class III beta-tubulin, TUBB3, in ovarian cancer cells.

Izutsu N, Maesawa C, Shibazaki M, Oikawa H, Shoji T, Sugiyama T, Masuda T.

Int J Oncol. 2008 Jun;32(6):1227-35.

PMID:
18497984
7.

[Expression of mesothelin mRNA and protein in ovarian carcinomas].

Bi SN, Dai SZ, Yao Q, Che YC, Wang N.

Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):288-91. Chinese.

PMID:
18788634
8.
9.

RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.

Bignone PA, Lee KY, Liu Y, Emilion G, Finch J, Soosay AE, Charnock FM, Beck S, Dunham I, Mungall AJ, Ganesan TS.

Oncogene. 2007 Feb 1;26(5):683-700. Epub 2006 Jul 31.

PMID:
16878154
10.

Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway.

Wang J, Cai J, Han F, Yang C, Tong Q, Cao T, Wu L, Wang Z.

Int J Gynecol Cancer. 2011 Aug;21(6):981-7. doi: 10.1097/IGC.0b013e31821d2543.

PMID:
21738044
11.

WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma.

Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Yamada H, Yamamoto R, Sakuragi N, Enokida H, Verma M, Dahiya R.

Cancer. 2005 Nov 1;104(9):1924-30.

12.

Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.

Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA.

Clin Cancer Res. 2003 May;9(5):1710-20.

14.
15.

Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.

Zhang H, Zhang S, Cui J, Zhang A, Shen L, Yu H.

Aust N Z J Obstet Gynaecol. 2008 Oct;48(5):505-9. doi: 10.1111/j.1479-828X.2008.00892.x.

PMID:
19032668
16.

Hypermethylation of the PTEN gene in ovarian cancer cell lines.

Schöndorf T, Ebert MP, Hoffmann J, Becker M, Moser N, Pur S, Göhring UJ, Weisshaar MP.

Cancer Lett. 2004 Apr 30;207(2):215-20.

PMID:
15072831
17.

[Disfigurement of p16INK4A gene expression in development of ovarian cancer and the mechanism].

Li M, Huang ZJ, Dong WH, Li XY, Wang XY, He XH, Wang H, Wang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jun;41(6):408-12. Chinese.

PMID:
16831366
18.

Aberrant promoter methylation of SPARC in ovarian cancer.

Socha MJ, Said N, Dai Y, Kwong J, Ramalingam P, Trieu V, Desai N, Mok SC, Motamed K.

Neoplasia. 2009 Feb;11(2):126-35.

19.
20.

Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.

Barbolina MV, Adley BP, Shea LD, Stack MS.

Cancer. 2008 Apr 1;112(7):1632-41. doi: 10.1002/cncr.23341.

Items per page

Supplemental Content

Write to the Help Desk